Global Cardiac Biomarkers Market 2017-2021
About Cardiac Biomarkers
Cardiac biomarkers are the substances used to detect the risk stratification of a patient with chest pain or suspected acute coronary syndrome (ACS). These biomarkers are released in blood when the heart is damaged or stressed. The tests that are carried out by introducing the cardiac biomarkers to the bloodstream help in determining the risks of associated heart conditions such as cardiac ischemia, ACS, myocardial infarction, and other associated heart diseases.
Technavio’s analysts forecast the global cardiac biomarkers market to grow at a CAGR of 12.97% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global cardiac biomarkers market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Cardiac Biomarkers Market 2017-2021
Technavio recognizes the following companies as the key players in the global cardiac biomarkers market: Abbott, Alere, and F. Hoffmann-La Roche.
Other Prominent Vendors in the market are: Advanced ImmunoChemical, AgPlus Diagnostics, AZSense, BD, BG Medicine, BioLegend, bioMérieux, Bio-Rad Laboratories, BODITECH MED, CAVADIS, Cisbio Bioassays, Creative Diagnostics, Critical Diagnostics, Cruinn Medical, DiaDexus, Enzo Life Sciences, Lepu Medical, LifeSign, LSI Medience, Merck, Monobind, Myriad RBM, NeoClone, NOWDiagnostics, Olink, Randox Laboratories, Response Biomedical, Signosis, Thermo Fisher Scientific, Tosoh Europe, Trinity Biotech, Trivitron Healthcare, and Wondfo.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is increased clinical trials. There is an increasing number of clinical trials for cardiac biomarkers. Manufacturers, universities, and research institutes are conducting various clinical trials to prove the efficacy of cardiac biomarkers. The increase in proficiency and accurate results of the cardiac biomarkers provide a high demand for them in the market.”
According to the report, one driver in the market is increasing use of cardiac biomarkers. The use of cardiac biomarkers helps in assessing the risk associated with diabetes, which invariably affects the cardiovascular system of the individual. It also helps in providing the rapid and accurate diagnosis for critically ill patients with presumed ACS. This induces the high adoption of cardiac biomarkers among the end-users to treat people with various cardiac diseases. Based on the study conducted by Universidade Federal do Rio Grande do Sul and associated hospitals in 2017, the people with type 2 diabetes are observed to be having cardiovascular risks as well.
Further, the report states that one challenge in the market is dominance of top vendors. The high market share of the top players such as Abbott, Alere, and F. Hoffmann La-Roche creates a market barrier for the small companies as well as the startups. There is a tendency of small start-ups getting acquired by the top manufacturers, which prevents them from establishing their business in the market. The hurdles faced by the small market players and the start-ups are mainly the budget constraints, innovative products, less number of clinical trials to prove the efficiency of the product, and brand image.
Abbott, Alere, F. Hoffmann-La Roche, Advanced ImmunoChemical, AgPlus Diagnostics, AZSense, BD, BG Medicine, BioLegend, bioMérieux, Bio-Rad Laboratories, BODITECH MED, CAVADIS, Cisbio Bioassays, Creative Diagnostics, Critical Diagnostics, Cruinn Medical, DiaDexus, Enzo Life Sciences, Lepu Medical, LifeSign, LSI Medience, Merck, Monobind, Myriad RBM, NeoClone, NOWDiagnostics, Olink, Randox Laboratories, Response Biomedical, Signosis, Thermo Fisher Scientific, Tosoh Europe, Trinity Biotech, Trivitron Healthcare, and Wondfo.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook